Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial-Reference-Cited by-同舟云学术

Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial

Published:2018-03-18 Issue:2 Volume:25 Page:158-168
ISSN:1526-6028
Container-title:Journal of Endovascular Therapy
language:en
Short-container-title:J Endovasc Ther

Author:

Moll Frans¹,Baumgartner Iris²,Jaff Michael³,Nwachuku Chuke⁴,Tangelder Marco¹,Ansel Gary⁵,Adams George⁶,Zeller Thomas⁷,Rundback John⁸,Grosso Michael⁴,Lin Min⁴,Mercur Michele F.⁴,Minar Erich⁹,

Affiliation:

1. Department of Vascular Surgery, University Medical Center Utrecht, the Netherlands

2. Cardiovascular Research Cluster, Universität Bern, Switzerland

3. Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA

4. Daiichi Sankyo Pharma Development, Edison, NJ, USA

5. Vascular Services, Ohio Health Heart & Vascular Physicians, Columbus, OH, USA

6. Cardiovascular and Peripheral Vascular Research, Rex Hospital University of North Carolina Health System, Raleigh, NC, USA

7. Department of Angiology, Universitäts Herzzentrum, Bad Krozingen, Germany

8. Interventional Institute, Holy Name Medical Center, Teaneck, NJ, USA

9. Internal Medicine, Medical University Vienna, Austria

Funder

Daiichi Sankyo Company

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,Surgery

Link

http://journals.sagepub.com/doi/pdf/10.1177/1526602818760488

Reference31 articles.

1. Antithrombotic Therapy in Peripheral Artery Disease

2. Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations)

3. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)

4. Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease

5. Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions;Interventional Cardiology Clinics;2024-10

2. Antithrombotic Strategies for Patients With Peripheral Artery Disease;Journal of the American College of Cardiology;2024-09

3. Use of Direct Oral Anticoagulants in Patients With Peripheral Artery Disease: A Meta-Analysis;The American Journal of Cardiology;2024-09

4. Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics;Current Pharmaceutical Design;2024-06

5. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia;Journal of Vascular Surgery;2024-06